MIT.nano CryoEM sample registration (v3)

General Information

You must set up a MUMMS account to use the CryoEM Facility (https://nanolms.mit.edu/mumms/registration.html).

Sample Information

Use this form for each new sample you would like to bring into the CryoEM facility for specimen preparation and/or imaging (Bioprep Lab, Aquilos, Talos Arctica, Titan Krios). To register multiple samples you will need to submit the form more than once.

We will work with you to establish procedures for your specimen that ensure safety for all users of the facility.

Have you previously registered this specimen material and its components for use in the cryo-EM facility?

Thank you for registering your sample!

After you receive sample approval, please proceed to the CryoEM session request form

Sample Details

Is your sample an inorganic nanomaterial or contain inorganic nanomaterials (material with at least one dimension <100 nm)?
Does your sample have any hazards other than biological?
Select method(s) of waste disposal appropriate for your sample.
Please select all that apply.
Will your sample be fixed (frozen does not count as fixed per NIH Guidelines) before entering MIT.nano?

Additional Sample Information

Biological Sample Information

Will your sample already be frozen on a TEM grid prior to bringing it to the CryoEM Facility?
Is your sample purified or crude?
What is the BioSafety Level (BSL) of your sample?
Please note: Our facility cannot handle BSL2+ samples.
Do you have a BRR?
Contact your MIT Biosafety Officer if you do not know your lab's BRR number. 
Ensure MIT.nano is on your BRR's locations.
Please Check the following in regards to your sample as it enters MIT.nano:

I understand that checking this box indicates that I have answered all of the above questions to the best of my knowledge and that I agree to only bring properly approved materials into MIT.nano. I will follow all policies and procedures outlined in MIT.nano documentation and training. If found out of compliance, I understand this may result in loss of access to MIT.nano facilities.